Xiangdong Xu

Xiangdong Xu

Auto-generated profile, based on publicly available information

Xiangdong Xu

VA San Diego Healthcare System

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Cell
Verified
Journal Article
Closed access
XXXiangdong Xu
Xiangdong Xu
DYDongmei Yang
Dongmei Yang
JDJian-Hua Ding
Jian-Hua Ding
WWWang Wang
Wang Wang
Pao-Hsien ChuPao-Hsien Chu
Pao-Hsien Chu
XFXiang-Dong Fu
Xiang-Dong Fu

1 February 2001 in Molecular Cell
Verified
Journal Article
Closed access
HWHuan-You Wang
Huan-You Wang
XXXiangdong Xu
Xiangdong Xu
JDJian-Hua Ding
Jian-Hua Ding
JBJohn R Bermingham
John R Bermingham
XFXiang-Dong Fu
Xiang-Dong Fu

12 February 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JDJian‐Hua Ding
Jian‐Hua Ding
XXXiangdong Xu
Xiangdong Xu
DYDongmei Yang
Dongmei Yang
Pao-Hsien ChuPao-Hsien Chu
Pao-Hsien Chu
NDNancy D Dalton
Nancy D Dalton
XFXiang‐Dong Fu
Xiang‐Dong Fu
Many genetic diseases are caused by mutations in cis ‐acting splicing signals, but few are triggered by defective trans ‐acting splicing factors. Here we report that tissue‐specific ablation of the splicing factor SC35 in the heart causes dilated cardiomyopathy (DCM). Although SC35 was deleted early in cardiogenesis by using the MLC‐2v‐Cre transgenic mouse, heart development appeared largely unaffected, with the DCM phenotype developing 3–5 weeks after birth and the mutant animals having a normal life span. This nonlethal phenotype allowed the identification of downregulated genes by microarray, one of which was the cardiac‐specific ryanodine receptor 2. We showed that downregulation of this critical Ca2+ release channel preceded disease symptoms and that the mutant cardiomyocytes exhibited frequency‐dependent excitation–contraction coupling defects. The implication of SC35 in heart disease agrees with a recently documented link of SC35 expression to heart failure and interference of splicing regulation during infection by myocarditis‐causing viruses. These studies raise a new paradigm for the etiology of certain human heart diseases of genetic or environmental origin that may be triggered by dysfunction in RNA processing.

26 October 2007 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
GYGene W Yeo
Gene W Yeo
XXXiangdong Xu
Xiangdong Xu
TLTiffany Y Liang
Tiffany Y Liang
AMAlysson R Muotri
Alysson R Muotri
CCChristian T Carson
Christian T Carson
FGFred H Gage
Fred H Gage
Human embryonic stem cells (hESCs) and neural progenitor (NP) cells are excellent models for recapitulating early neuronal development in vitro, and are key to establishing strategies for the treatment of degenerative disorders. While much effort had been undertaken to analyze transcriptional and epigenetic differences during the transition of hESC to NP, very little work has been performed to understand post-transcriptional changes during neuronal differentiation. Alternative RNA splicing (AS), a major form of post-transcriptional gene regulation, is important in mammalian development and neuronal function. Human ESC, hESC-derived NP, and human central nervous system stem cells were compared using Affymetrix exon arrays. We introduced an outlier detection approach, REAP (Regression-based Exon Array Protocol), to identify 1,737 internal exons that are predicted to undergo AS in NP compared to hESC. Experimental validation of REAP-predicted AS events indicated a threshold-dependent sensitivity ranging from 56% to 69%, at a specificity of 77% to 96%. REAP predictions significantly overlapped sets of alternative events identified using expressed sequence tags and evolutionarily conserved AS events. Our results also reveal that focusing on differentially expressed genes between hESC and NP will overlook 14% of potential AS genes. In addition, we found that REAP predictions are enriched in genes encoding serine/threonine kinase and helicase activities. An example is a REAP-predicted alternative exon in the SLK (serine/threonine kinase 2) gene that is differentially included in hESC, but skipped in NP as well as in other differentiated tissues. Lastly, comparative sequence analysis revealed conserved intronic cis-regulatory elements such as the FOX1/2 binding site GCAUG as being proximal to candidate AS exons, suggesting that FOX1/2 may participate in the regulation of AS in NP and hESC. In summary, a new methodology for exon array analysis was introduced, leading to new insights into the complexity of AS in human embryonic stem cells and their transition to neural stem cells. Deriving neural progenitors (NP) from human embryonic stem cells (hESC) is the first step in creating homogeneous populations of cells that will differentiate into myriad neuronal subtypes necessary to form a human brain. During alternative RNA splicing (AS), noncoding sequences (introns) in a pre-mRNA are differentially removed in different cell types and tissues, and the remaining sequences (exons) are joined to form multiple forms of mature RNA, playing an important role in cellular diversity. The authors utilized Affymetrix exon arrays with probes targeting hundreds of thousands of exons to study AS comparing human ES to NP. To accomplish this, a novel computational method, REAP (Regression-based Exon Array Protocol), is introduced to analyze the exon array data. The authors showed that REAP candidates are consistent with other types of methods for discovering alternative exons. In addition, REAP candidate alternative exons are enriched in genes encoding serine/theronine kinases and helicase activities. An example is the alternative exon in the SLK (serine/threonine kinase 2) gene that is included in hESC, but excluded in NP as well as in other differentiated tissues. Finally, by comparing genomic sequences across multiple mammals, the authors identified dozens of conserved candidate binding sites that were enriched proximal to REAP candidate exons.

1 November 2005 in Molecular Cell
Verified
Journal Article
Closed access
SLShengrong Lin
Shengrong Lin
RXRan Xiao
Ran Xiao
PSPeiqing Sun
Peiqing Sun
XXXiangdong Xu
Xiangdong Xu
XFXiang-Dong Fu
Xiang-Dong Fu

1 December 2005 in Methods
Verified
Journal Article
Closed access
XXXiangdong Xu
Xiangdong Xu
XFXiang-Dong Fu
Xiang-Dong Fu